Third Circuit remands class certification order in Provigil antitrust case
MLex Summary: The US Court of Appeals for the Third Circuit has reversed an order that certified a class of direct purchasers in litigation accusing Mylan and Ranbaxy Laboratories of illegally delaying...To view the full article, register now.
Already a subscriber? Click here to view full article